These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 22997972

  • 21. Moving from the second to the third generation Roche PTH assays: what are the consequences for clinical practice?
    Dupuy AM, Bargnoux AS, Morena M, Lauret E, Souberbielle JC, Cavalier E, Cristol JP.
    Clin Chem Lab Med; 2018 Dec 19; 57(2):244-249. PubMed ID: 30183664
    [Abstract] [Full Text] [Related]

  • 22. Parathyroidectomy as a therapeutic tool for targeting the recommended NKF-K/DOQI ranges for serum calcium, phosphate and parathyroid hormone in dialysis patients.
    Mazzaferro S, Pasquali M, Farcomeni A, Vestri AR, Filippini A, Romani AM, Barresi G, Pugliese F.
    Nephrol Dial Transplant; 2008 Jul 19; 23(7):2319-23. PubMed ID: 18281320
    [Abstract] [Full Text] [Related]

  • 23. KDOQI US commentary on the KDIGO clinical practice guideline for the prevention, diagnosis, evaluation, and treatment of hepatitis C in CKD.
    Gordon CE, Balk EM, Becker BN, Crooks PA, Jaber BL, Johnson CA, Michael MA, Pereira BJ, Uhlig K, Levin A.
    Am J Kidney Dis; 2008 Nov 19; 52(5):811-25. PubMed ID: 18971009
    [Abstract] [Full Text] [Related]

  • 24. Inter-method variability in PTH measurement: implication for the care of CKD patients.
    Souberbielle JC, Boutten A, Carlier MC, Chevenne D, Coumaros G, Lawson-Body E, Massart C, Monge M, Myara J, Parent X, Plouvier E, Houillier P.
    Kidney Int; 2006 Jul 19; 70(2):345-50. PubMed ID: 16788691
    [Abstract] [Full Text] [Related]

  • 25. Performance characteristics of five automated CA 19-9 assays.
    La'ulu SL, Roberts WL.
    Am J Clin Pathol; 2007 Mar 19; 127(3):436-40. PubMed ID: 17276945
    [Abstract] [Full Text] [Related]

  • 26. Prevalence of chronic kidney disease-mineral and bone disorder in incident peritoneal dialysis patients and its association with short-term outcomes.
    Chuang SH, Wong HC, Vathsala A, Lee E, How PP.
    Singapore Med J; 2016 Nov 19; 57(11):603-609. PubMed ID: 26778726
    [Abstract] [Full Text] [Related]

  • 27. Very low or undetectable intact parathyroid hormone levels in patients with surgically verified parathyroid adenomas.
    Bhadada SK, Cardenas M, Bhansali A, Mittal BR, Behera A, Chanukya GV, Nahar U, Rao DS.
    Clin Endocrinol (Oxf); 2008 Sep 19; 69(3):382-5. PubMed ID: 18284640
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Differences between serum and plasma for intact parathyroid hormone measurement in patients with chronic renal failure in routine clinical practice.
    Twomey PJ, Whitlock T, Pledger DR.
    J Clin Pathol; 2005 Sep 19; 58(9):1000-1. PubMed ID: 16126890
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Critical issues of PTH assays in CKD.
    Komaba H, Goto S, Fukagawa M.
    Bone; 2009 Apr 19; 44(4):666-70. PubMed ID: 19159701
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. [The French clinician's guide to the Kidney disease: Improving global outcomes (KDIGO) for chronic kidney disease-mineral and bone disorders (CKD-MBD)].
    Jean G, Chazot C.
    Nephrol Ther; 2010 Jun 19; 6(3):151-7. PubMed ID: 20399169
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Parathyroid hormone measurement in chronic kidney disease: Impact of inter-method variability on mineral bone disease assessment.
    White CA, Sarabia S, Collier CP, McCudden C, Holden RM.
    Clin Biochem; 2021 Aug 19; 94():62-66. PubMed ID: 33895125
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Impact of the Kidney Disease Outcomes Quality Initiative (KDOQI) Clinical Practice Guidelines for Bone Metabolism and Disease in a large dialysis network.
    Wald R, Tentori F, Tighiouart H, Zager PG, Miskulin DC.
    Am J Kidney Dis; 2007 Feb 19; 49(2):257-66. PubMed ID: 17261428
    [Abstract] [Full Text] [Related]

  • 40. Multicenter evaluation of a new immunoassay for intact PTH measurement on the Elecsys System 2010 and 1010.
    Hermsen D, Franzson L, Hoffmann JP, Isaksson A, Kaufman JM, Leary E, Müller C, Nakatsuka K, Nishizawa Y, Reinauer H, Riesen W, Roth HJ, Steinmüller T, Troch T, Bergmann P.
    Clin Lab; 2002 Feb 19; 48(3-4):131-41. PubMed ID: 11934215
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.